Crescendo Biologics Ltd has recruited Richard Williams, an experienced project manager, to oversee the chemistry, manufacturing and control (CMC) activities for the development of the company’s targeted T cell enhancing therapeutics. Dr Williams previously directed CMC at the antibody company Kymab Ltd. Prior to this, he held senior positions at Crucell, CAT/Medimmune, Acambis and Schering Plough Animal Health. He received a PhD in microbial physiology from the University of Surrey in the UK.
Crescendo Biologics announced the appointment on 18 October 2018.
Copyright 2018 Evernow Publishing Ltd